Key facts
- This page summarizes Ronnen Armon's Form 3 filing for Cellebrite DI Ltd. (CLBT).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 08:23.
Ronnen Armon - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)
- Reporting relationship
- Chief Products & Technologies Officer
- Issuer ticker
- CLBT
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Ronnen Armon
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ronnen Armon filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001970877
Primary reporting owner
Armon Ronnen
- Relationship
- Chief Products & Technologies Officer
- Address
- 94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
- Signature
- /s/ Ronnen Armon
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLBT
holding
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 277,844
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLBT
holding
Derivative
Stock options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 60,606
- Exercise price
- $6.60
- Footnotes
- F6
CLBT
holding
Derivative
Stock options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 80,808
- Exercise price
- $4.95
- Footnotes
- F7
CLBT
holding
Derivative
Stock options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 43,440
- Exercise price
- $11.51
- Footnotes
- F8
CLBT
holding
Derivative
Stock options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 43,440
- Exercise price
- $11.51
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Includes 29,320 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on February 14, 2023, of which 7,330 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
Footnote F2
Includes 24,030 Ordinary Shares that are represented by RSUs that were granted on March 20, 2024, of which 2,670 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.
Footnote F3
Includes 27,768 Ordinary Shares that are represented by RSUs that were granted on March 20, 2024, of which 2,136 vest on each of March 20, 2026 and every three months thereafter through March 20, 2029.
Footnote F4
Includes 5,341 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on March 20, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through March 20, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement.
Footnote F5
Includes 5,341 Ordinary Shares that are represented by PSUs that were granted on March 20, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through March 20, 2028.
Footnote F6
These stock options are fully vested and exercisable.
Footnote F7
Of these stock options, 60,608 are fully vested and exercisable and 5,050 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027.
Footnote F8
Of these stock options, 19,005 are fully vested and exercisable and 2,715 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.
Footnote F9
Of these stock options, 15,204 are fully vested and exercisable and 2,172 vest on each of March 20, 2026 and every three months thereafter through March 20, 2029.
SEC remarks
Chief Products & Technologies Officer